Commentary on “Solving the benign prostatic hyperplasia puzzle”

doi:10.1016/j.ajur.2016.09.007

Asian Journal of Urology, 2018, 5 (1): 10-11 doi: 10.1016/j.ajur.2016.09.007

Commentary

Current Issue | Archive | Adv Search

Commentary on “Solving the benign prostatic hyperplasia puzzle”

Thomas Dominique^a,Chughtai Bilal^a,Kaplan Steven^b

^a Department of Urology, Weill Cornell Medicine/New-York Presbyterian Hospital, New York, NY, USA
^b Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Abstract
Related Citation (0)

[1]	H. Lepor . Pathophysiology, epidemiology natural history of benign prostatic hyperplasia. Rev Urol, 6 (Suppl. 9)(2004), pp. S3-S10
[2]	K.T. Foo . Solving the benign prostatic hyperplasia puzzle. 3(2016), pp. 6-9
[3]	A. Hirayama, S. Samma, K. Fujimoto, A. Yamaguchi, T. Akiyama , Y. Fukui. Comparison of parameters to determine the cause of urinary disturbance in men with prostate volume less than 20 milliliters. Int J Urol, 9 ( 2002), pp. 554-559 discussion 560
[4]	G.C. Luo, K.T. Foo, T. Kuo, G. Tan . Diagnosis of prostate adenoma and the relationship between the site of prostate adenoma and bladder outlet obstruction. Singap Med J, 54(2013), pp. 482-486
[5]	T. Yoshida, H. Kinoshita, K. Yoshida, T. Mishima, H. Taniguchi, M. Yanishi , et al. Intravesical prostatic protrusion as a predicting factor for the adverse clinical outcome in patients with symptomatic benign prostatic enlargement treated with dutasteride. Urology, 91(2016), pp. 154-157
[6]	S.J. Chia, C.T. Heng, S.P. Chan, K.T. Foo . Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int, 91(2003), pp. 371-374
[7]	J.H. Kim, J.S. Shim, H. Choi, D.G. Moon, J.G. Lee, J.J. Kim , et al. Terminal dribbling in male patients with lower urinary tract symptoms: relationship with International Prostate Symptom Score and with intravesical prostatic protrusion. BMC Urol, 15(2015), p. 89
[8]	L.S. Lee, H.G. Sim, K.B. Lim, D. Wang, K.T. Foo . Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Int J Urol, 17(2010), pp. 69-74
[9]	B. Chughtai, J.C. Forde, D.D. Thomas, L. Laor, T. Hossack, H.H. Woo , et al. Benign prostatic hyperplasia. Nat Rev Dis Prim, 2(2016), p. 16031
[10]	B. Chughtai, B.M. Mian . High risk prostate cancer: evolving definition and approach to management. Can J Urol, 15(2008), pp. 4375-4380